Literature DB >> 29223432

Contemporary risk model for inhospital major bleeding for patients with acute myocardial infarction: The acute coronary treatment and intervention outcomes network (ACTION) registry®-Get With The Guidelines (GWTG)®.

Nihar R Desai1, Kevin F Kennedy2, David J Cohen2, Traci Connolly3, Deborah B Diercks4, Mauro Moscucci5, Stephen Ramee6, John Spertus2, Tracy Y Wang7, Robert L McNamara8.   

Abstract

BACKGROUND: Major bleeding is a frequent complication for patients with acute myocardial infarction (AMI) and is associated with significant morbidity and mortality.
OBJECTIVE: To develop a contemporary model for inhospital major bleeding that can both support clinical decision-making and serve as a foundation for assessing hospital quality.
METHODS: An inhospital major bleeding model was developed using the Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines (ACTION Registry-GWTG) database. Patients hospitalized with AMI between January 1, 2012 and December 31, 2013 across 657 hospitals were used to create a derivation cohort (n=144,800) and a validation cohort (n=96,684). Multivariable hierarchal logistic regression was used to identify significant predictors of major bleeding. A simplified risk score was created to enable prospective risk stratification for clinical care.
RESULTS: The rate of major bleeding in the overall population was 7.53%. There were 8 significant, independent factors associated with major bleeding: presentation after cardiac arrest (OR 2.99 [2.77-3.22]); presentation in cardiogenic shock (OR 2.22 [2.05-2.40]); STEMI (OR 1.72 [1.65-1.80]); presentation in heart failure (OR 1.55 [1.47-1.63]); baseline hemoglobin less than 12 g/dL (1.55 [1.48-1.63]); heart rate (per 10 beat per minute increase) (OR 1.13 [1.12-1.14]); weight (per 10 kilogram decrease) (OR 1.12 [1.11-1.14]); creatinine clearance (per 5-mL decrease) (OR 1.07 [1.07-1.08]). The model discriminated well in the derivation (C-statistic = 0.74) and validation (C-statistic = 0.74) cohorts. In the validation cohort, a risk score for major bleeding corresponded well with observed bleeding: very low risk (2.2%), low risk (5.1%), moderate risk (10.1%), high risk (16.3%), and very high risk (25.2%).
CONCLUSION: The new ACTION Registry-GWTG inhospital major bleeding risk model and risk score offer a robust, parsimonious, and contemporary risk-adjustment method to support clinical decision-making and enable hospital quality assessment. Strategies to mitigate risk should be developed and tested as a means to lower costs and improve outcomes in an era of alternative payment models.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29223432     DOI: 10.1016/j.ahj.2017.08.004

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

1.  askMUSIC: Leveraging a Clinical Registry to Develop a New Machine Learning Model to Inform Patients of Prostate Cancer Treatments Chosen by Similar Men.

Authors:  Gregory B Auffenberg; Khurshid R Ghani; Shreyas Ramani; Etiowo Usoro; Brian Denton; Craig Rogers; Benjamin Stockton; David C Miller; Karandeep Singh
Journal:  Eur Urol       Date:  2018-10-11       Impact factor: 20.096

2.  The Association of Frailty With In-Hospital Bleeding Among Older Adults With Acute Myocardial Infarction: Insights From the ACTION Registry.

Authors:  John A Dodson; Judith S Hochman; Matthew T Roe; Anita Y Chen; Sarwat I Chaudhry; Stuart Katz; Hua Zhong; Martha J Radford; Jacob A Udell; Akshay Bagai; Gregg C Fonarow; Martha Gulati; Jonathan R Enriquez; Kirk N Garratt; Karen P Alexander
Journal:  JACC Cardiovasc Interv       Date:  2018-11-26       Impact factor: 11.195

Review 3.  Development of In Vitro Endothelialised Stents - Review.

Authors:  Jitsuro Tsukada; P Mela; M Jinzaki; H Tsukada; T Schmitz-Rode; F Vogt
Journal:  Stem Cell Rev Rep       Date:  2021-08-17       Impact factor: 5.739

4.  Cangrelor Use Patterns and Transition to Oral P2Y12 Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO Registry.

Authors:  Jennifer A Rymer; Deepak L Bhatt; Dominick J Angiolillo; Miguel Diaz; Kirk N Garratt; Ron Waksman; Laura Edwards; Gudaye Tasissa; Khalid Salahuddin; Hijrah El-Sabae; Carmen Dell'Anna; Linda Davidson-Ray; Jeffrey B Washam; E Magnus Ohman; Tracy Y Wang
Journal:  J Am Heart Assoc       Date:  2022-05-27       Impact factor: 6.106

5.  Development and validation of a prognostic prediction model for antithrombotic-related chronic subdural hematoma in patients with recent acute myocardial infarction.

Authors:  Peng Zhou; Jindong Wan; Fei Ran; Feng Gao; Dachun Yang; Xiaozhen Dai; Yun Sun; Peijian Wang
Journal:  Cardiovasc Diagn Ther       Date:  2020-12

6.  Impact of Prior Digestive System Disease on In-Hospital Gastrointestinal Bleeding in Patients with Acute Myocardial Infarction.

Authors:  Yu Liu; Le-Feng Wang; Li-Hong Liu; Xin-Chun Yang; Zheng-Hong Ren; Kui-Bao Li; Mu-Lei Chen; Hong-Shi Wang; Jiu-Chang Zhong; Li Xu; Zhu-Hua Ni; Wei-Ming Li; Kun Xia; Da-Peng Zhang; Hao Sun; Zong-Sheng Guo; Yong-Hui Chi; Ji-Fang He; Zhi-Yong Zhang; Feng Jiang
Journal:  Risk Manag Healthc Policy       Date:  2021-03-22

7.  Derivation and validation of a combined in-hospital mortality and bleeding risk model in acute myocardial infarction.

Authors:  Hong Nyun Kim; Jang Hoon Lee; Hyeon Jeong Kim; Bo Eun Park; Se Yong Jang; Myung Hwan Bae; Dong Heon Yang; Hun Sik Park; Yongkeun Cho; Myung Ho Jeong; Jong-Seon Park; Hyo-Soo Kim; Seung-Ho Hur; In-Whan Seong; Myeong-Chan Cho; Chong-Jin Kim; Shung Chull Chae
Journal:  Int J Cardiol Heart Vasc       Date:  2021-02-22

8.  The Effects of Ticagrelor Combined with Tirofiban on Coagulation Function, Serum Myocardial Injury Markers, and Inflammatory Factor Levels in Patients with Acute Myocardial Infarction after Percutaneous Coronary Intervention.

Authors:  Fang Li; Shuhui Wang; Lei Wang; Feng Liu; Zhen Meng; Jia Liu
Journal:  Comput Math Methods Med       Date:  2022-04-28       Impact factor: 2.809

Review 9.  Comparing health outcomes between coronary interventions in frail patients aged 75 years or older with acute coronary syndrome: a systematic review.

Authors:  Gregory W van Wyk; Shlomo Berkovsky; David Fraile Navarro; Enrico Coiera
Journal:  Eur Geriatr Med       Date:  2022-07-31       Impact factor: 3.269

10.  Long non-coding RNA SENCR alleviates hypoxia/reoxygenation-induced cardiomyocyte apoptosis and inflammatory response by sponging miR-1.

Authors:  Minghe Chen; Yini Guo; Zongli Sun; Xiangjiang Meng
Journal:  Cardiovasc Diagn Ther       Date:  2021-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.